Stephen I. Pelton

13.8k total citations
241 papers, 10.0k citations indexed

About

Stephen I. Pelton is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Stephen I. Pelton has authored 241 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Epidemiology, 91 papers in Microbiology and 43 papers in Infectious Diseases. Recurrent topics in Stephen I. Pelton's work include Pneumonia and Respiratory Infections (146 papers), Respiratory viral infections research (93 papers) and Bacterial Infections and Vaccines (90 papers). Stephen I. Pelton is often cited by papers focused on Pneumonia and Respiratory Infections (146 papers), Respiratory viral infections research (93 papers) and Bacterial Infections and Vaccines (90 papers). Stephen I. Pelton collaborates with scholars based in United States, United Kingdom and Netherlands. Stephen I. Pelton's co-authors include Jerome O. Klein, Jonathan A. Finkelstein, Susan S. Huang, Kimberly M. Shea, William P. Hanage, Marc Lipsitch, Katherine Hsu, Abbie E. Stevenson, Paul A. Shurin and David Strutton and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Stephen I. Pelton

232 papers receiving 9.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen I. Pelton United States 56 6.6k 3.4k 1.5k 1.2k 1.1k 241 10.0k
Ronald de Groot Netherlands 52 7.9k 1.2× 2.7k 0.8× 3.5k 2.3× 1.8k 1.5× 230 0.2× 251 12.7k
Henry R. Shinefield United States 52 7.9k 1.2× 3.2k 0.9× 2.3k 1.5× 713 0.6× 262 0.2× 176 11.5k
Steven Black United States 51 8.8k 1.3× 3.6k 1.0× 2.5k 1.6× 866 0.7× 285 0.3× 209 12.6k
Robert S. Heyderman United Kingdom 51 4.3k 0.6× 1.6k 0.5× 3.3k 2.1× 395 0.3× 231 0.2× 309 11.1k
George R. Siber United States 57 9.5k 1.4× 5.1k 1.5× 2.1k 1.4× 1.5k 1.2× 395 0.4× 187 14.7k
Amanda Leach Australia 43 3.1k 0.5× 1.4k 0.4× 640 0.4× 1.3k 1.0× 1.1k 1.0× 192 6.1k
Keith S. Reisinger United States 41 4.5k 0.7× 1.1k 0.3× 1.1k 0.7× 462 0.4× 387 0.3× 108 6.0k
Ram Yogev United States 49 4.2k 0.6× 1.4k 0.4× 3.4k 2.2× 1.1k 0.9× 94 0.1× 298 9.1k
Heikki Peltola Finland 63 8.7k 1.3× 5.8k 1.7× 2.5k 1.6× 659 0.5× 114 0.1× 257 13.7k
Helena Käyhty Finland 54 8.6k 1.3× 6.1k 1.8× 804 0.5× 550 0.5× 269 0.2× 239 10.6k

Countries citing papers authored by Stephen I. Pelton

Since Specialization
Citations

This map shows the geographic impact of Stephen I. Pelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Pelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Pelton more than expected).

Fields of papers citing papers by Stephen I. Pelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen I. Pelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Pelton. The network helps show where Stephen I. Pelton may publish in the future.

Co-authorship network of co-authors of Stephen I. Pelton

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen I. Pelton. A scholar is included among the top collaborators of Stephen I. Pelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen I. Pelton. Stephen I. Pelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pelton, Stephen I., et al.. (2023). Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review. Vaccines. 11(10). 1594–1594. 4 indexed citations
3.
5.
Mitchell, Patrick K., Taj Azarian, Nicholas J. Croucher, et al.. (2019). Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13. Microbial Genomics. 5(2). 13 indexed citations
6.
Mrkvan, Tomáš, Stephen I. Pelton, Javier Ruiz‐Guiñazú, Arto A. Palmu, & Dorota Borys. (2018). Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience. Expert Review of Vaccines. 17(9). 797–818. 16 indexed citations
9.
Vergison, Anne, Ron Dagan, Adriano Arguedas, et al.. (2010). Otitis media and its consequences: beyond the earache. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 64 indexed citations
10.
Nozyce, Molly L., Andrew Wiznia, Sharon Nachman, et al.. (2006). A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children. PEDIATRICS. 117(3). 763–770. 139 indexed citations
11.
Bauchner, Howard, Colin D. Marchant, Alice Bisbee, et al.. (2006). Effectiveness of Centers for Disease Control and Prevention Recommendations for Outcomes of Acute Otitis Media. PEDIATRICS. 117(4). 1009–1017. 15 indexed citations
12.
Sáez‐Llorens, Xavier, Richard A. Rode, Perry Gomez, et al.. (2003). Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 22(3). 216–223. 102 indexed citations
13.
Yogev, Ram, Sophia Lee, Andrew Wiznia, et al.. (2002). Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection. The Pediatric Infectious Disease Journal. 21(2). 119–125. 6 indexed citations
14.
Hausdorff, William P., Greg Yothers, Ron Dagan, et al.. (2002). Multinational study of pneumococcal serotypes causing acute otitis media in children. The Pediatric Infectious Disease Journal. 21(11). 1008–1016. 98 indexed citations
15.
Read, Jennifer S., Carl E. Frasch, Kenneth Rich, et al.. (1998). The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. The Pediatric Infectious Disease Journal. 17(5). 391–397. 23 indexed citations
16.
Barnett, Elizabeth D., Jerome O. Klein, David W. Teele, et al.. (1994). Single dose ceftriaxone for acute otitis media. 34. 219. 1 indexed citations
17.
Barenkamp, Stephen J., Paul A. Shurin, Colin D. Marchant, et al.. (1984). Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain?. The Journal of Pediatrics. 105(4). 533–537. 50 indexed citations
18.
Shurin, Paul A., Stephen I. Pelton, Ira B. Tager, & Dennis L. Kasper. (1980). Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. The Journal of Pediatrics. 97(3). 364–369. 86 indexed citations
19.
Lietman, Paul S., Paul A. Shurin, Stephen I. Pelton, et al.. (1980). Trimethoprim-sulfamethoxazole compared with ampicillin in the treatment of acute otitis media. The Journal of Pediatrics. 96(6). 1081–1087. 31 indexed citations
20.
Shurin, Paul A., Virgil M. Howie, Stephen I. Pelton, John H. Ploussard, & Jerome O. Klein. (1978). Bacterial etiology of otitis media during the first six weeks of life. The Journal of Pediatrics. 92(6). 893–896. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026